|
|
Volumn 62, Issue 1, 2012, Pages 76-77
|
|
Whole-body magnetic resonance imaging and prostate cancer metastases: A new gold standard of detection, but does it help us and at what cost?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
PROSTATE SPECIFIC ANTIGEN;
ABDOMINAL RADIOGRAPHY;
ANDROGEN DEPRIVATION THERAPY;
AORTA ANEURYSM;
BONE METASTASIS;
BONE SCINTISCANNING;
CANCER DIAGNOSIS;
CANCER RISK;
CANCER SCREENING;
CLINICAL ARTICLE;
COMPARATIVE STUDY;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC TEST ACCURACY STUDY;
DIFFUSION WEIGHTED IMAGING;
FALSE POSITIVE RESULT;
GLEASON SCORE;
GOLD STANDARD;
HIGH RISK POPULATION;
HUMAN;
ILIAC ARTERY ANEURYSM;
INCIDENTAL FINDING;
KIDNEY POLYCYSTIC DISEASE;
LIVER HEMANGIOMA;
LYMPHADENOPATHY;
MALE;
NOTE;
PELVIS RADIOGRAPHY;
PRIORITY JOURNAL;
PROSTATE CANCER;
SENSITIVITY AND SPECIFICITY;
THORAX RADIOGRAPHY;
WHOLE BODY IMAGING;
WHOLE BODY MRI;
|
|
EID: 84861626580
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2012.02.059 Document Type: Editorial |
|
Times cited : (11)
|
|
References (11)
|
